CD44 and cancer: Here, glycosaminoglycan hyaluronan binds to its receptor CD44 at the surface of the neoplastic cells and subsequently cross-links with activated CD44 receptors expressed on the endothelium, suggesting that cancer cells with elevated hyaluronic acid synthase activity and high CD44 expression exhibit an increased potential to metastasize [58, 59].